(Q44343861)

2 December 2017

title

Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis (English)

1 reference

2 December 2017

0 references

1 reference

Moreau R

1

1 reference

2 December 2017

Cailmail S

series ordinal

2

1 reference

2 December 2017

Hamon G

series ordinal

3

1 reference

2 December 2017

Lebrec D

series ordinal

4

1 reference

2 December 2017

publication date

1 September 1996

1 reference

Journal of Gastroenterology and Hepatology

2 December 2017

published in

1 reference

2 December 2017

volume

11

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

857-863

1 reference

Vasopressin gene expression in rats with experimental cirrhosis

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00093.X

Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00093.X

Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00093.X

Naloxone does not alter haemodynamics in cirrhosis. Studies in humans and rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00093.X

Lack of vascular hyporesponsiveness to the L-type calcium channel activator, Bay K 8644, in rats with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1996.TB00093.X

10.1111/J.1440-1746.1996.TB00093.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference